1) sector studies (see Assobiotec reports at https://assobiotec.federchimica.it/) show that the Biotechnology sector is also rapidly expanding in Italy
2) Employment data reported by Almalaurea indicate that three years after graduation, 92.7% of graduates in Industrial Biotechnology (LM-8) in Italy are engaged in paid work. This figure is higher than the average for graduates in Medical Biotechnology LM-9 (88.1%), Agricultural Biotechnology LM-7 (87%) or in master’s degrees in the biological area LM-6 (84.9%);
3) Three years after graduation, between 2019 and 2023, employment data for graduates of the MSc in Biotechnology from the University of Rome Tor Vergata have always been higher than the national average (Almalaurea).
4) In 2023, 100% of graduates declared that they were overall satisfied with the course (ANVUR data)
5) The MSc in Biotechnology at the University of Rome Tor Vergata is the LM-8 course in Italy with the highest internationalization index (ANVUR data)
6) Our courses involve professionals from biotechnology companies and the world of Clinical Research to promote a connection between university teaching and the world of work
7) The Master’s Degree in Biotechnology offers a Curriculum in Clinical Research, unique in Italy. It is the first and so far the only Master’s program in Italy aimed at training students with all the necessary knowledge to perform essential and leading roles in the world of clinical research (Data Manager, Clinical Research Associate, Clinical Research Coordinator). All graduates from this curriculum have all found a very rapid job placement. Follow the link here for more information
